OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
Portfolio Pulse from
OrthoPediatrics Corp. reported a record preliminary unaudited revenue of $205 million for the full year 2024, marking a 38% year-over-year growth. The company also issued guidance for a record adjusted EBITDA in 2025.
January 13, 2025 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OrthoPediatrics Corp. reported a record revenue of $205 million for 2024, a 38% increase from the previous year, and provided guidance for a record adjusted EBITDA in 2025.
The significant revenue growth of 38% year-over-year and the positive guidance for 2025 suggest strong business performance and potential for future profitability, likely boosting investor confidence and positively impacting the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100